Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 80
Number Thumbnail Title Author Date Votes Views
80 Prestige Biopharma to Present Phase 1 Clinical Data for Pancreatic Cancer Drug Candidate PBP1510 at ESMO 2026
김** | 2026.10.23 | Votes 0 | Views 177
김** 2026.10.23 0 177
79 Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships
김** | 2026.10.07 | Votes 0 | Views 780
김** 2026.10.07 0 780
78 Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear
김** | 2026.10.01 | Votes 0 | Views 809
김** 2026.10.01 0 809
77 Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management
김** | 2026.09.30 | Votes 0 | Views 680
김** 2026.09.30 0 680
76 Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue
김** | 2026.09.28 | Votes 0 | Views 977
김** 2026.09.28 0 977
75 Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago
김** | 2026.09.18 | Votes 0 | Views 1112
김** 2026.09.18 0 1112
74 Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications
김** | 2026.09.17 | Votes 0 | Views 897
김** 2026.09.17 0 897
73 Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging
김** | 2026.09.09 | Votes 0 | Views 1448
김** 2026.09.09 0 1448
72 Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market
김** | 2026.09.03 | Votes 0 | Views 1828
김** 2026.09.03 0 1828
71 Prestige Biopharma’s Tuznue Secures Brazilian GMP Certification, Supporting Latin American Approval Process
김** | 2026.08.25 | Votes 0 | Views 2460
김** 2026.08.25 0 2460

Read Prestige news >>